Classification of heart failure: A farewell to ejection fraction?
作者信息
Lüscher Thomas F
机构信息
Royal Brompton and Harefield Hospitals, Heart Division and Imperial College, National Heart and Lung Institute; London-United Kingdom; and Center for Molecular Cardiology, University of Zurich; Zurich-Switzerland.
出版信息
Anatol J Cardiol. 2021 Jan;25(1):2-6. doi: 10.14744/AnatolJCardiol.2020.70138.
Abstract
摘要
相似文献
1
Classification of heart failure: A farewell to ejection fraction?
Anatol J Cardiol. 2021 Jan;25(1):2-6. doi: 10.14744/AnatolJCardiol.2020.70138.
2
[Heart failure with preserved left ventricular ejection fraction].
Internist (Berl). 2019 Sep;60(9):925-942. doi: 10.1007/s00108-019-0653-0.
3
Comparison of the reliability of E/E' to estimate pulmonary capillary wedge pressure in heart failure patients with preserved ejection fraction versus those with reduced ejection fraction.
Int J Cardiovasc Imaging. 2015 Dec;31(8):1497-502. doi: 10.1007/s10554-015-0718-7. Epub 2015 Jul 28.
4
Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study.
Eur J Heart Fail. 2012 Mar;14(3):240-7. doi: 10.1093/eurjhf/hfs003. Epub 2012 Feb 7.
5
Phenotyping Heart Failure According to the Longitudinal Ejection Fraction Change: Myocardial Strain, Predictors, and Outcomes.
J Am Heart Assoc. 2020 Jun 16;9(12):e015009. doi: 10.1161/JAHA.119.015009. Epub 2020 Jun 10.
6
[Heart failure with mid-range ejection fraction. Looking for Middle Earth?].
G Ital Cardiol (Rome). 2018 Jan;19(1):32-43. doi: 10.1714/2852.28777.
7
Left-to-right ventricular volume ratio predicts prognosis in heart failure with preserved ejection fraction: when simple is better.
J Cardiovasc Med (Hagerstown). 2023 Aug 1;24(8):561-563. doi: 10.2459/JCM.0000000000001526.
8
Heart failure with preserved ejection fraction: a precursor of heart failure with reduced ejection fraction or a distinct syndrome?
Int J Cardiol. 2011 May 19;149(1):139-40. doi: 10.1016/j.ijcard.2011.02.007. Epub 2011 Mar 3.
9
Prognostic Impact of Worsening Renal Function in Hospitalized Heart Failure Patients With Preserved Ejection Fraction: A Report From the JASPER Registry.
J Card Fail. 2019 Aug;25(8):631-642. doi: 10.1016/j.cardfail.2019.04.009. Epub 2019 Apr 18.
10
Noninvasive Assessment of Preload Reserve Enhances Risk Stratification of Patients With Heart Failure With Reduced Ejection Fraction.
Circ Cardiovasc Imaging. 2018 May;11(5):e007160. doi: 10.1161/CIRCIMAGING.117.007160.
本文引用的文献
1
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
N Engl J Med. 2021 Jan 14;384(2):105-116. doi: 10.1056/NEJMoa2025797. Epub 2020 Nov 13.
2
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet. 2020 Sep 12;396(10253):759-769. doi: 10.1016/S0140-6736(20)31792-X. Epub 2020 Aug 29.
3
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
N Engl J Med. 2020 Oct 8;383(15):1413-1424. doi: 10.1056/NEJMoa2022190. Epub 2020 Aug 28.
4
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
N Engl J Med. 2020 May 14;382(20):1883-1893. doi: 10.1056/NEJMoa1915928. Epub 2020 Mar 28.
5
A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction.
Eur Heart J. 2020 Jul 1;41(25):2356-2362. doi: 10.1093/eurheartj/ehaa184.
6
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.
7
Lumpers and splitters: the bumpy road to precision medicine.
Eur Heart J. 2019 Oct 21;40(40):3292-3296. doi: 10.1093/eurheartj/ehz644.
8
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
N Engl J Med. 2019 Oct 24;381(17):1609-1620. doi: 10.1056/NEJMoa1908655. Epub 2019 Sep 1.
9
Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?
Eur Heart J. 2020 Mar 21;41(12):1249-1257. doi: 10.1093/eurheartj/ehz550.
10
Prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in older adults.
Eur Heart J. 2019 Feb 7;40(6):529-538. doi: 10.1093/eurheartj/ehy713.
Zotero 插件